In both cohorts , patients were randomly assigned @:@ via an interactive web-based randomisation system , stratified by disease site and disease-free interval , to receive continuous oral letrozole @ mg daily or continuous oral letrozole @ mg daily plus oral palbociclib @ mg , given once daily for @ weeks followed by @ week off over @-day cycles .